Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ethyl 3,4-dihydroxybenzoate
Cat. No.:
OB0225LY-0353
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
Ethyl 3,4-dihydroxybenzoate is a phenolic compound with antioxidant properties, simple structure and diverse functions.
Synonym:
3943-89-3; Ethyl protocatechuate; 3,4-Dihydroxybenzoic acid ethyl ester; Protocatechuic acid ethyl ester; Benzoic acid, 3,4-dihydroxy-, ethyl ester
CAS No.:
3943-89-3
Compound CID:
77547
Formula:
C9H10O4
Formula Weight:
182.17
Specification
Relative Density:
1.2481 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ethyl 3,4-dihydroxybenzoate can be used in natural product chemistry studies or play an important role in the study of antioxidant mechanisms.
Library Information
Targets:
NO synthase; Reactive oxygen species; HIF/HIF prolyl-hydroxylase
Pathways:
Apoptosis; Chromatin/Epigenetic; Metabolism; Autophagy; NF-κB; Immunology/Inflammation
Plate Number:
AOCL-5
Plate Location:
e7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
22.5 mg/mL; 123.51 mM
